Teva Pharmaceuticals
TEVA
TEVA
433 hedge funds and large institutions have $5.66B invested in Teva Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 54 funds opening new positions, 130 increasing their positions, 132 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
5.28% more ownership
Funds ownership: 44.16% → 49.45% (+5.3%)
2% more funds holding
Funds holding: 425 → 433 (+8)
2% less repeat investments, than reductions
Existing positions increased: 130 | Existing positions reduced: 132
Holders
433
Holding in Top 10
19
Calls
$277M
Puts
$174M
Top Buyers
| 1 | +$283M | |
| 2 | +$116M | |
| 3 | +$98.3M | |
| 4 |
SSM
Sound Shore Management
Greenwich,
Connecticut
|
+$80.8M |
| 5 |
IAM
Ion Asset Management
Herzliya,
Israel
|
+$58.7M |
Top Sellers
| 1 | -$103M | |
| 2 | -$42.6M | |
| 3 | -$40.3M | |
| 4 |
Renaissance Technologies
New York
|
-$25.7M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$25.7M |